BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 5082511)

  • 1. Detection and properties of an acid -galactosidase (ceramidetrihexosidase) in normal human urine.
    Rietra PJ; Tager JM; Borst P
    Biochim Biophys Acta; 1972 Oct; 279(3):436-45. PubMed ID: 5082511
    [No Abstract]   [Full Text] [Related]  

  • 2. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.
    Brady RO; Tallman JF; Johnson WG; Gal AE; Leahy WR; Quirk JM; Dekaban AS
    N Engl J Med; 1973 Jul; 289(1):9-14. PubMed ID: 4196713
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation and properties of an affinity column adsorbent for differentiation of multiple forms of -galactosidase activity.
    Mapes CA; Sweeley CC
    J Biol Chem; 1973 Apr; 248(7):2461-70. PubMed ID: 4121458
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction of the enzymic defect in cultured fibroblasts from patients with Fabry's disease: treatment with purified alpha-galactosidase from ficin.
    Dawson G; Matalon R; Li YT
    Pediatr Res; 1973 Aug; 7(8):684-90. PubMed ID: 4732107
    [No Abstract]   [Full Text] [Related]  

  • 5. Fabry's disease as an -galactosidosis: evidence for an -configuration in trihexosyl ceramide.
    Bensaude I; Callahan J; Philippart M
    Biochem Biophys Res Commun; 1971 May; 43(4):913-8. PubMed ID: 5563756
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on galactosyl ceramide and lactosyl ceramide beta-galactosidase.
    Wenger DA
    Chem Phys Lipids; 1974 Dec; 13(4):327-9. PubMed ID: 4452215
    [No Abstract]   [Full Text] [Related]  

  • 7. Fabry's disease: differentiation between two forms of -galactosidase by myoinositol.
    Crawhall JC; Banfalvi M
    Science; 1972 Aug; 177(4048):527-8. PubMed ID: 5050485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitor-sensitive sites of galactosyl ceramide galactosidase.
    Arora RC; Lin YN; Radin NS
    Arch Biochem Biophys; 1973 May; 156(1):77-83. PubMed ID: 4738302
    [No Abstract]   [Full Text] [Related]  

  • 9. Human kidney alpha-galactosidase. Multiplicity and enzyme activities for ceramide trihexoside and some aryl alpha-galactosides.
    Kano I; Yamakawa T
    J Biochem; 1974 Feb; 75(2):347-54. PubMed ID: 4837447
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydrolysis of ceramide trihexoside by a specific -galactosidase from human liver.
    Ho MW
    Biochem J; 1973 May; 133(1):1-10. PubMed ID: 4721621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the alpha-galactosidase deficiency in Fabry's disease using antibodies against the purified enzyme.
    Rietra PJ; Molenaar JL; Hamers MN; Tager JM; Borst P
    Eur J Biochem; 1974 Jul; 46(1):89-98. PubMed ID: 4212108
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for a terminal -D-galactopyranosyl residue in galactosylgalactosylglucosylceramide from human kidney.
    Clarke JT; Wolfe LS; Perlin AS
    J Biol Chem; 1971 Sep; 246(18):5563-9. PubMed ID: 5096082
    [No Abstract]   [Full Text] [Related]  

  • 13. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes.
    Desnick RJ; Allen KY; Desnick SJ; Raman MK; Bernlohr RW; Krivit W
    J Lab Clin Med; 1973 Feb; 81(2):157-71. PubMed ID: 4683418
    [No Abstract]   [Full Text] [Related]  

  • 14. An enzymological approach to the lipidoses.
    Tallman JF; Pentchev PG; Brady RO
    Enzyme; 1974; 18(1):136-49. PubMed ID: 4211795
    [No Abstract]   [Full Text] [Related]  

  • 15. The adnormal biochemistry of inherited disorders of lipid metabolism.
    Brady RO
    Fed Proc; 1973 Jun; 32(6):1660-7. PubMed ID: 4351098
    [No Abstract]   [Full Text] [Related]  

  • 16. Fabry's disease: evidence for a physically altered -galactosidase.
    Ho MW; Beutler S; Tennant L; O'Brien JS
    Am J Hum Genet; 1972 May; 24(3):256-66. PubMed ID: 5028966
    [No Abstract]   [Full Text] [Related]  

  • 17. The glycosphingolipids and glycosyl hydrolases of human blood platelets.
    Snyder PD; Desnick RJ; Krivit W
    Biochem Biophys Res Commun; 1972 Mar; 46(5):1857-65. PubMed ID: 5015230
    [No Abstract]   [Full Text] [Related]  

  • 18. Correction of enzymatic deficiencies by renal transplantation: Fabry's disease.
    Desnick RJ; Simmons RL; Allen KY; Woods JE; Anderson CF; Najarian JS; Krivit W
    Surgery; 1972 Aug; 72(2):203-11. PubMed ID: 4559379
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on isolation and characterization of ceramide trihexosidase.
    Sweeley CC; Mapes CA
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):206-13. PubMed ID: 4373101
    [No Abstract]   [Full Text] [Related]  

  • 20. Presence of alpha-anomeric glycosidic configuration in the glycolipids accumulated in kidney with Fabry's disease.
    Handa S; Ariga T; Miyatake T; Yamakawa T
    J Biochem; 1971 Mar; 69(3):625-7. PubMed ID: 5551655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.